Ligand validation:9SS9

X8Z: L-CAPTOPRIL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9SS9_X8Z_B_708	87%	51%	0.074	0.952	0.58	1.18	-	2	0	0	100%	1
4C2P_X8Z_A_709	41%	52%	0.142	0.856	0.67	1.06	-	-	0	0	100%	1
4DPR_X8Z_A_702	86%	20%	0.077	0.952	2	1.29	3	4	3	0	100%	1
9CV3_X8Z_A_304	86%	58%	0.087	0.96	0.79	0.69	1	-	0	0	100%	0.81
9CV5_X8Z_A_303	85%	54%	0.093	0.966	0.77	0.87	-	-	0	0	100%	0.9
2X8Z_X8Z_A_1615	85%	33%	0.085	0.956	1.32	1.25	2	1	0	0	100%	1
4PQA_X8Z_A_401	81%	53%	0.095	0.952	0.6	1.08	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.